Literature DB >> 9157136

PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity.

J A Ribes1, A H Limper, M J Espy, T F Smith.   

Abstract

Although PCR detection of Pneumocystis carinii DNA has been described, little is known about the sensitivity or specificity of the assay in routine laboratory practice. We had the unique opportunity to use a bronchoalveolar lavage (BAL) specimen bank with samples for which the direct examination results for P. carinii were known. DNA purified from 129 selected specimens was amplified by using the primers described previously (A. E. Wakefield, F. J. Pixley, S. Banerji, K. Sinclair, R. F. Miller, E. R. Moton, and J. M. Hopkin, Mol. Biochem. Parasitol. 43:69-76, 1990). Of the 129 specimens, 37 were positive for P. carinii by direct examination. All 37 specimens were positive for P. carinii by PCR, yielding a 100% sensitivity and 100% negative predictive value for the assay. An additional 23 specimens were repeatedly positive for P. carinii by PCR but were not positive by direct examination. Review of the patient charts for these specimens with discordant results demonstrated that five of the patients were actually positive for P. carinii, as determined by either biopsy or examination of repeat or prior BAL specimens. A response to empiric therapy for P. carinii pneumonia was seen in an additional two patients. Of the remaining specimens, 8 produced no significant isolates other than P. carinii, while 12 contained culture-confirmed significant respiratory pathogens in addition to P. carinii (two fungal, nine bacterial, and one viral pathogen). Cytomegalovirus, which was of unknown significance, was isolated from 16 additional specimens. Overall, the specificity of the PCR assay was 79.3% compared to the results of direct examination. We hypothesized that the apparently poor specificity of the PCR assay was due to the increased sensitivity of the assay compared to that of direct examination. The sensitivity of the PCR assay was therefore assessed with BAL specimens containing P. carinii cysts. Serial dilutions of this preparation were evaluated by direct examination and PCR. PCR was found to be 100-fold more sensitive than direct examination, which detected one to two cysts per amplification. No false-positive results were detected in controls containing no DNA or by using target DNA from various fungal, viral, or bacterial respiratory pathogens. We conclude that PCR detection of P. carinii in BAL specimens is very sensitive and should be considered for patients whose specimens do not yield a diagnosis. The increased sensitivity of the PCR assay may help to identify those patients with low-titer infections who might benefit from directed antibiotic therapy for P. carinii and would otherwise be missed by direct examination alone.

Entities:  

Mesh:

Year:  1997        PMID: 9157136      PMCID: PMC229684          DOI: 10.1128/jcm.35.4.830-835.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Does laboratory recovery of Pneumocystis carinii always mean clinically significant disease?

Authors:  G Contini; R Romani; V Vullo; S Delia; F Sorice
Journal:  AIDS       Date:  1992-12       Impact factor: 4.177

2.  Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.

Authors:  A H Limper; K P Offord; T F Smith; W J Martin
Journal:  Am Rev Respir Dis       Date:  1989-11

3.  Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

Authors:  P D Walzer; D P Perl; D J Krogstad; P G Rawson; M G Schultz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

4.  Use of bronchoscopy in the diagnosis of infection in the immunocompromised host.

Authors:  R P Baughman
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

5.  Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin.

Authors:  A E Wakefield; F J Pixley; S Banerji; K Sinclair; R F Miller; E R Moxon; J M Hopkin
Journal:  Mol Biochem Parasitol       Date:  1990-11       Impact factor: 1.759

6.  Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimens.

Authors:  C Atzori; J J Lu; B Jiang; M S Bartlett; G Orlando; S F Queener; J W Smith; A Cargnel; C H Lee
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

7.  Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients. A clinical and cost-analysis study.

Authors:  C Chouaid; P Roux; I Lavard; J L Poirot; B Housset
Journal:  Am J Clin Pathol       Date:  1995-07       Impact factor: 2.493

8.  Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood.

Authors:  G Y Lipschik; V J Gill; J D Lundgren; V A Andrawis; N A Nelson; J O Nielsen; F P Ognibene; J A Kovacs
Journal:  Lancet       Date:  1992-07-25       Impact factor: 79.321

9.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.

Authors:  L L Pifer; W T Hughes; S Stagno; D Woods
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

10.  Interlobar variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers.

Authors:  A H Limper; U Specks; W M Brutinel; W J Martin; M S Rohrbach
Journal:  J Lab Clin Med       Date:  1993-06
View more
  15 in total

1.  PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis.

Authors:  Yuan Lu; Guoya Ling; Chenyi Qiang; Qinshou Ming; Cong Wu; Ke Wang; Zouxiao Ying
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

Review 2.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

3.  Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia.

Authors:  Hans Henrik Larsen; Henry Masur; Joseph A Kovacs; Vee J Gill; Victoria A Silcott; Palaniandy Kogulan; Janine Maenza; Margo Smith; Daniel R Lucey; Steven H Fischer
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups.

Authors:  A Sing; K Trebesius; A Roggenkamp; H Rüssmann; K Tybus; F Pfaff; J R Bogner; C Emminger; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Authors:  Philippe M Hauser; Jacques Bille; Cornelia Lass-Flörl; Christian Geltner; Marta Feldmesser; Michael Levi; Hitesh Patel; Victoria Muggia; Barbara Alexander; Martin Hughes; Sarah A Follett; Xiaohui Cui; Flora Leung; Gillian Morgan; Adrian Moody; David S Perlin; David W Denning
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

6.  Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study.

Authors:  Catherine M Samuel; Andrew Whitelaw; Craig Corcoran; Brenda Morrow; Nei-Yuan Hsiao; Marco Zampoli; Heather J Zar
Journal:  BMC Infect Dis       Date:  2011-11-28       Impact factor: 3.090

7.  Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens.

Authors:  A M Caliendo; P L Hewitt; J M Allega; A Keen; K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  FlindersTechnology Associates (FTA) filter paper-based DNA extraction with polymerase chain reaction (PCR) for detection of Pneumocystis jirovecii from respiratory specimens of immunocompromised patients.

Authors:  Surang Nuchprayoon; Wilai Saksirisampant; Siraya Jaijakul; Issarang Nuchprayoon
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

9.  Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples.

Authors:  J Helweg-Larsen; J S Jensen; T Benfield; U G Svendsen; J D Lundgren; B Lundgren
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP).

Authors:  Julie R Harris; Barbara J Marston; Nalinee Sangrujee; Desiree DuPlessis; Benjamin Park
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.